A novel series of 2,5-substituted tryptamine derivatives as vascular 5HT(1B/1D) receptor antagonists

被引:31
|
作者
Moloney, GP
Robertson, AD
Martin, GR
MacLennan, S
Mathews, N
Dodsworth, S
Sang, PY
Knight, C
Glen, R
机构
[1] AMRAD,RICHMOND,VIC 3121,AUSTRALIA
[2] ROCHE BIOSCI,DEPT MOL PHARMACOL,NEUROBIOL UNIT,PALO ALTO,CA 94304
[3] GLAXO WELLCOME RES & DEV LTD,RES GRP,DEPT MED CHEM,STEVENAGE SG1 2NY,HERTS,ENGLAND
[4] ASTRA PHARMACEUT,ABBOTSFORD,VIC 3067,AUSTRALIA
[5] TRIPOS INC,ST LOUIS,MO 63144
基金
英国惠康基金;
关键词
D O I
10.1021/jm9605849
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The design, synthesis, and activity of a novel series of 2,5-substituted tryptamine derivatives at vascular 5HT(1B)-like receptors is described. Several important auxiliary binding sites of the 5HT(1B)-like receptor have been proposed following various modifications to the 2-substituent and especially to the methylene- or ethylene-linked 5-side chain. Careful design of new molecules based on a proposed pharmacophoric model of the 5HT(1B)-like receptor has resulted in the discovery of ethyl 3-[2-(dimethylamino)ethyl]-5-[2-(2,5-dioxo-1-imidazolidinyl)ethyl]-1H-indole-2-carboxylate (40), a highly potent, silent, competitive, and selective antagonist which shows affinity at the vascular 5HT(1B)-like receptors only. Changes to the size of the 2-ester substituent have a significant effect on affinity at the 5HT(1B)-like receptor and other receptors. Prudent placement of the carbonyl substituent in the heterocycle of the 5-side chain is crucial for good affinity and selectivity over the 5HT(2A) and other receptors. Several key structural and electronic features were identified which are crucial for producing antagonism within a tryptamine-based series. An electron deficient indole ring system appears essential in order to achieve antagonism, and this is achieved by the inclusion of electron-withdrawing groups at the 2-position of the indole ring. The molecule displacement within the receptor resulting from the inclusion of the bulky 2-substituents also enhances antagonism as this results in the removal of the pi electon density of the indole ring from the region of the receptor normally occupied by the indole ring of 5HT. There also appears to be a structural requirement on the side chain incorporating the protonatable nitrogen, and this is achieved by the inclusion of the bulky 2-ester group which neighbors the 3-ethylamine side chain.
引用
收藏
页码:2347 / 2362
页数:16
相关论文
共 50 条
  • [1] Central sites of actions of zolmitriptan and sumatriptan: 5HT(1B), 5HT(1D) and 5HT(1F) receptor distribution
    Pascual, J
    Castro, ME
    Pazos, A
    CEPHALALGIA, 1997, 17 (06) : 711 - 711
  • [2] NOVEL TRYPTAMINE DERIVATIVES - A SERIES OF NITROGEN LINKED 5-HETEROCYCLYL INDOLES AS POTENT AND SELECTIVE 5HT(1D) RECEPTOR AGONISTS
    REEVE, AJ
    STREET, LJ
    BAKER, R
    STERNFELD, F
    GUIBLIN, AR
    DAVEY, WB
    BEER, MS
    STANTON, JA
    HARGREAVES, RJ
    SCHOLEY, K
    GRAHAM, MI
    SOHAL, B
    MATASSA, VG
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 180 - MEDI
  • [3] Synthesis and pharmacological profile of a series of 2,5-substituted-N,N-dimethyltryptamine derivatives as novel antagonists for the vascular 5-HT1B-like receptor
    Moloney, GP
    Martin, GR
    Mathews, N
    Hobbs, H
    Dodsworth, S
    Sang, PY
    Knight, C
    Maxwell, M
    Glen, RC
    JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1999, (19): : 2713 - 2723
  • [4] Novel 5-HT1A/1B/1D receptors antagonists with potent 5-HT reuptake inhibitory activity
    Serafinowska, Halina T.
    Blaney, Frank E.
    Lovell, Peter J.
    Merlo, Giancarlo G.
    Scott, Claire M.
    Smith, Paul W.
    Starr, Kathryn R.
    Watson, Jeannette M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (20) : 5581 - 5585
  • [5] 5-HT1B/1D antagonists and depression
    Halazy, S
    Lamothe, M
    JorandLebrun, C
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1997, 7 (04) : 339 - 352
  • [6] Microiontophoretic application of serotonin (5HT)1B/1D agonists inhibits trigeminal cell firing in the cat
    Storer, RJ
    Goadsby, PJ
    BRAIN, 1997, 120 : 2171 - 2177
  • [8] Design, synthesis, and structure-Activity relationship studies of novel tryptamine derivatives as 5-HT 1B receptor agonists
    Fang, Liping
    He, Shan
    Yin, Peng
    Wang, Ning
    Zhang, Bin
    Jin, Haixiao
    JOURNAL OF MOLECULAR STRUCTURE, 2022, 1265
  • [9] Conformationally constrained 5-(thienyl)tryptamine derivatives as serotonin 5-HT1B/1D receptor agonists:: Potential treatments for migraine
    Slassi, A
    Meng, CQ
    Dyne, K
    Wang, X
    Lee, DKH
    Kamboj, R
    McCallum, KL
    Mazzacco, L
    Rakhit, S
    MEDICINAL CHEMISTRY RESEARCH, 1999, 9 (09) : 668 - 674
  • [10] Alterations in serotonin(1B) (5HT(1B)) receptor subtypes in the brain of ethanol-treated rats
    Pandey, SC
    Piano, MR
    Pandey, GN
    DRUG AND ALCOHOL DEPENDENCE, 1996, 41 (03) : 219 - 225